Evidence map›Paper›PMID 29526065›Full record

ArticleJournal of Korean Neurosurgical Society2018

Nationwide Mortality Data after Flow-Diverting Stent Implantation in Korea.

Tackeun Kim, O-Ki Kwon, Heeyoung Lee, Min Jai Cho, Hyun Jean Jeong, Seung Pil Ban

Open access · goldAbstract read
In one paragraph

Article in Journal of Korean Neurosurgical Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Tackeun KimDepartment of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
O-Ki KwonDepartment of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Heeyoung LeeSeoul National University College of Medicine, Seoul, Korea.
Min Jai ChoDepartment of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Hyun Jean JeongDepartment of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Seung Pil BanDepartment of Neurosurgery, Seoul National University Bundang Hospital, Seongnam, Korea.
Seoul National University · KRSeoul National University Bundang Hospital · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate nationwide statistics on flow-diverting stent usage for cerebral aneurysm treatment and related mortality data.

methodsWe requested data extraction from the National Health Insurance Service claims database using electronic data interchange codes (J3207064, J3207073). Patient and hospital information as well as death statistics were collected from the database.

resultsA total of 169 procedures were performed using flow-diverting stents for cerebral aneurysm treatment from November 2014 to December 2016 in Korea. The majority of primary diagnosis was unruptured intracranial aneurysm. During the study period, nine subjects died, including one patient initially diagnosed with subarachnoid hemorrhage. The crude mortality rate was 5.3%. Five patients died within one month after the procedure; therefore, the estimated periprocedural mortality rate was 3.0±1.3%. The mortality rate as of the last day of 2016 was 6.3±2.1%.

conclusionIn a 171 person-year follow-up in a Korean series, nine deaths occurred after flow-diverting stent treatment. The crude mortality rate in Korea (5.3%) was higher than that reported in a previous meta-analysis (3.8%).

Indexed as

Flow diverterFlow diverting stentIntracranial aneurysmKoreaMortalityStents

Identifiers

PMID29526065
PMCPMC5853200
OpenAlexW2788053732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.